{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:56Z","timestamp":1786119416808,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/hjh.0b013e328332b79b","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T10:33:20Z","timestamp":1261046000000},"page":"170-177","source":"Crossref","is-referenced-by-count":26,"title":["Does the ratio of serum aldosterone to plasma renin activity predict the efficacy of diuretics in hypertension? Results of RENALDO"],"prefix":"10.1097","volume":"28","author":[{"given":"Hari K","family":"Parthasarathy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khamis","family":"Alhashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex D","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan D","family":"Struthers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon T","family":"McInnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M","family":"Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20210208","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R2-23-20210208","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study","volume":"371","author":"Douma","year":"2008","journal-title":"Lancet"},{"key":"R3-23-20210208","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/S0140-6736(08)60809-0","article-title":"Deja vu for primary aldosteronism","volume":"371","author":"Kaplan","year":"2008","journal-title":"Lancet"},{"key":"R4-23-20210208","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11906-007-0066-7","article-title":"Resistant hypertension and aldosteronism","volume":"9","author":"Pimenta","year":"2007","journal-title":"Curr Hypertens Rep"},{"key":"R5-23-20210208","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(05)74868-6","article-title":"Potentially high prevalence of primary aldosteronism in a primary-care population","volume":"353","author":"Lim","year":"1999","journal-title":"Lancet"},{"key":"R6-23-20210208","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1046\/j.1365-2125.1999.00070.x","article-title":"Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study","volume":"48","author":"Lim","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"R7-23-20210208","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00004872-200103000-00001","article-title":"A review of the medical treatment of primary aldosteronism","volume":"19","author":"Lim","year":"2001","journal-title":"J Hypertens"},{"key":"R8-23-20210208","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2261-7-14","article-title":"Does the aldosterone:renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) study","volume":"7","author":"Parthasarathy","year":"2007","journal-title":"BMC Cardiovasc Disord"},{"key":"R9-23-20210208","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/bmj.322.7285.531","article-title":"Blood pressure measuring devices: recommendations of the European Society of Hypertension","volume":"322","author":"O'Brien","year":"2001","journal-title":"BMJ"},{"key":"R10-23-20210208","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00004872-199503000-00003","article-title":"Elevated blood pressure during the first two hours of ambulatory blood pressure monitoring: a study comparing consecutive twenty-four-hour monitoring periods","volume":"13","author":"Prasad","year":"1995","journal-title":"J Hypertens"},{"key":"R11-23-20210208","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0009-8981(80)90050-9","article-title":"A microassay for active and total renin concentration in human plasma based on antibody trapping","volume":"101","author":"Millar","year":"1980","journal-title":"Clin Chim Acta"},{"key":"R12-23-20210208","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/HJH.0b013e328302c9fe","article-title":"Effect on blood pressure of lumiracoxib versus ibuprofen in patients with osteoarthritis and controlled hypertension: a randomized trial","volume":"26","author":"MacDonald","year":"2008","journal-title":"J Hypertens"},{"key":"R13-23-20210208","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3810\/pgm.1996.10.94","article-title":"Resistant hypertension. Suggestions for dealing with the problem.","volume":"100","author":"Gandhi","year":"1996","journal-title":"Postgrad Med"},{"key":"R14-23-20210208","first-page":"822","article-title":"Resistant hypertension: an overview","volume":"12","author":"McAlister","year":"1996","journal-title":"Can J Cardiol"},{"key":"R15-23-20210208","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2125.2007.03072.x","article-title":"Prevalence and treatment of isolated and concurrent hypertension and hypercholesterolaemia in the United Kingdom","volume":"65","author":"MacDonald","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"R16-23-20210208","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R17-23-20210208","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.jhh.1001013","article-title":"High prevalence of primary aldosteronism in the Tayside hypertension clinic population","volume":"14","author":"Lim","year":"2000","journal-title":"J Hum Hypertens"},{"key":"R18-23-20210208","first-page":"2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore","volume":"85","author":"Loh","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-23-20210208","first-page":"800","article-title":"High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension","volume":"127","author":"Mosso","year":"1999","journal-title":"Rev Med Chil"},{"issue":"Suppl 1","key":"R20-23-20210208","doi-asserted-by":"crossref","first-page":"83s","DOI":"10.1016\/S0753-3322(00)80019-0","article-title":"Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital","volume":"54","author":"Nishikawa","year":"2000","journal-title":"Biomed Pharmacother"},{"key":"R21-23-20210208","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.HYP.0000259805.18468.8c","article-title":"Effect of spironolactone on blood pressure in subjects with resistant hypertension","volume":"49","author":"Chapman","year":"2007","journal-title":"Hypertension"},{"key":"R22-23-20210208","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/CIRCULATIONAHA.107.690396","article-title":"The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio","volume":"116","author":"Hood","year":"2007","journal-title":"Circulation"},{"key":"R23-23-20210208","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.amjhyper.2005.06.010","article-title":"Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?","volume":"18","author":"Mahmud","year":"2005","journal-title":"Am J Hypertens"},{"key":"R24-23-20210208","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan","year":"2004","journal-title":"N Engl J Med"},{"key":"R25-23-20210208","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"R26-23-20210208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004872-200201000-00003","article-title":"The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism?","volume":"20","author":"Lim","year":"2002","journal-title":"J Hypertens"},{"key":"R27-23-20210208","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archinte.168.11.1159","article-title":"Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion","volume":"168","author":"Gaddam","year":"2008","journal-title":"Arch Intern Med"},{"key":"R28-23-20210208","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1365-2265.2007.03116.x","article-title":"Effect of variation in CYP11B1 and CYP11B2 on corticosteroid phenotype and hypothalamic-pituitary-adrenal axis activity in hypertensive and normotensive subjects","volume":"68","author":"Freel","year":"2008","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004872-201001000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:11:39Z","timestamp":1786039899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004872-201001000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e328332b79b","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}